You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
AAV2-ASPA-Based Metabolic Intervention for Alzheimer's Disease
SBC: ASKLEPIOS BIOPHARMACEUTICAL, INC. Topic: NIAAbstract We propose to initiate preclinical development of a gene therapeutic targeted to Alzheimer's Disease. The World Health Organization's and Alzheimer's Disease International's report on Dementia (2012) recognizes that the global burden of AlzheimerDisease is forecast to worsen significantly with prevalence predicted to double every 20 years. Interventions that could prov ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A Bullet Proof vascular graft to prevent dialysis access cannulation injury
SBC: Innavasc Medical, Inc. Topic: 400Project Summary Abstract Synthetic arteriovenous grafts AVGs can provide life sustaining vascular access for dialysis patients but are subject to multiple modes of failure and complications related to chronic needle cannulation poor graft identification delayed access and bleeding These graft needle cannulation associated complications translate to millions of dollars in health care expense ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Active Control of a Scramjet Engine
SBC: Innoveering, LLC Topic: AF15AT19In this effort, Innoveering will integrate and test a closed-loop active control system for scramjet isolator shock system positioning. The approach is to control the fuel flow to the engine to position the shock train leading edge at a specified location in the isolator. The control system includes three basic elements: a shock position sensing system based, a fast response fuel valve that adjust ...
STTR Phase II 2016 Department of DefenseAir Force -
Adaptive Cyber-secure Cross-layer Communications-Classification System (AC4S): Cyber Superiority for Air Force Combatant Commanders Using Cyber-domain
SBC: ANDRO COMPUTATIONAL SOLUTIONS LLC Topic: AF08BT06ABSTRACT: In this effort selected SBIR technologies will be matured and merged to establish the Adaptive Cyber-secure Cross-layer Communications-Classification System (AC4S) for enhancing the throughput, spectral efficiency, speed, reliability and security performance of software defined radio (SDR) communication networks. One of the core technologies in the AC4S architecture is the Cyber Superior ...
STTR Phase II 2016 Department of DefenseAir Force -
Adaptive Cyber-secure Cross-layer Communications-Classification System (AC4S): Dynamic Cross-layer Routing Using Cognitive Spectrum Allocation (AXL-RO
SBC: ANDRO COMPUTATIONAL SOLUTIONS LLC Topic: AF10BT09ABSTRACT: In this effort selected SBIR technologies will be matured and merged to establish the Adaptive Cyber-secure Cross-layer Communications-Classification System (AC4S) for enhancing the throughput, spectral efficiency, speed, reliability and security performance of software defined radio (SDR) communication networks. One of the core technologies that forms the basis of AC4S is the AXL-ROSA s ...
STTR Phase II 2016 Department of DefenseAir Force -
A Millimeter-wave Tunable Cavity for Ultra-sensitive Solids and Liquids DNP-NMR at Low Budget
SBC: DOTY SCIENTIFIC, INC. Topic: NIA? DESCRIPTION (provided by applicant): NMR is probably the most powerful and widely used analytical technique for structure determination and function elucidation of molecules of all types, but it suffers from low sensitivity, particularly for insoluble biological macromolecules. Dynamic Nuclear Polarization (DNP) with Magic Angle Spinning (MAS) has recently demonstrated S/N gains exceeding t ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Aminoglycosides with reduced ototoxicity
SBC: NUBAD LLC Topic: NIAIDPROJECT SUMMARY Aminoglycosides are one of the cheapest and well known antibiotics in clinical use for over years but one of the major limitations in their use is their ototoxicity We are developing fast and low cost methods to develop aminoglycosides with anti ribosomal activities and reduced toxicity In this project we will identify novel aminoglycoside antibacterials that show reduced ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A novel protein engineering tool for rapid manufacturing of designer nucleosomes
SBC: Epicypher, Inc. Topic: 103PROJECT SUMMARY Nucleosomes are the basic building blocks of chromatin and composed of bp DNA wrapped around a core histone octamer Chromatin function is controlled by the dynamic addition removal of histone post translational modifications PTMs Significantly alterations in specific PTMs are associated with changes in gene expression driving the emergence progression of many cancer ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A novel therapeutic approach for Acute Lung Injury/ARDS
SBC: BIOMARCK PHARMACEUTICALS, LTD Topic: NHLBIDESCRIPTION (provided by applicant): The objective of the proposed project is to advance the development of novel peptides targeting MARCKS (Myristoylated Alanine-Rich C Kinase Substrate) protein as platform drug molecules for the treatment of Acute Lung Injury (ALI) and its more severe form, Acute Respiratory Distress Syndrome (ARDS), thereby providing the first pharmacologic therapeutic for this ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Anti-biofilm agents for the treatment of pulmonary infection in cystic fibrosis p
SBC: AGILE SCIENCES, INC. Topic: NIAIDDESCRIPTION provided by applicant The leading cause of mortality in patients with cystic fibrosis CF is pulmonary failure from lung infections and the predominant organism isolated from these infections is the bacterium Pseudomonas aeruginosa Lung infections of CF patients persist over the lifetime of the patients and are impossible to eradicate due to the ability of bacteria to form biofi ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health